<DOC>
	<DOCNO>NCT01229410</DOCNO>
	<brief_summary>This study evaluate pharmacokinetics brimonidine follow single intravitreal administration 200 ug 400 ug Brimonidine Tartrate Posterior Segment Drug Delivery System patient 2 , 4 8 week prior undergo par plana vitrectomy .</brief_summary>
	<brief_title>Pharmacokinetics Brimonidine Tartrate Posterior Segment Delivery System Patients Undergoing Pars Plana Vitrectomy</brief_title>
	<detailed_description />
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Temazepam</mesh_term>
	<criteria>Plan par plana vitrectomy repair posterior segment condition ( eg , epiretinal membrane , macular hole , vitreomacular traction ) Visual acuity nonstudy eye well 20/200 History par plana vitrectomy retinal detachment surgery study eye Surgery laser treatment study eye within 3 month Use brimonidine , apraclonidine topical alpha2agonist either eye within 2 week Intraocular infection inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>